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ABSTRACT 
In the twelve month period from March 1992 to February 
1993. 266 consecutive children with measles were admitted 
to the children's unit at Queen Elizabeth Central Hospital 
(QECH). Blantyre. During the 12 month period the overall 
mortality was 10.9%; mortality was highest (22.5%) in chil-
dren 12-23 months age. One-third of the children admitted 
were under 9 months of age. not eligible for measles vaccina-
tion. Pneumonia complicated illness of 30% of cases and 
was the greatest clinical predictor of mortality. Among 
inf.mts under 9 months of age, who were receiving inappro-
priate food supplementation before 4 months of age the risk 
of death was 6.4 rimes the risk of death in children who were 
not receiving food supplementation. Other aspects of 
measles epidemiology are discussed. 
Introduction 
Measle~ remains a mysterious disease although it has been 
well documented from ancient times by the Persian Physician 
Rhazes in 850 A.D. There still remain many unanswered 
questions concerning its pathology and the human immune 
response to measles. At a time when considerable attention 
is focused on the immuno-suppressant viruses HIV I and 
HIV 2 (and retroviruses in general) it is sometimes forgotten 
that the measles virus has long been known to cause severe 
immuno-suppression in children. While in the majority of 
patients the immuno-suppression is temporary some chil-
dren develop a condition. subacute sclerosing pan-encephali-
tis (SSPE). In this condition the measles virus acts as a 
"slow" virus; afrer a latent period (from months to years) the 
virus reactivates in the central nervous system of patients. 
These patients, often adolescents, will usually die from 
progressive neurological damage within a year of onset of 
their symptoms. The exact trigger for this reactivation is not 
known; the probable mechanism is an auto-immune 
response against neural tissue. 
In the acute illness the measles virus is well recognised to 
cause a significant depression of cell mediated immunity. 
This is manifest by loss of reactivity to tuberculin in the child 
and reactivation of clinical TB may occur at this time. 
Vitamin A given early in the course of measles signifi-
candy decreases morbidity and mortality. Even measles 
patients in nonvitamin A deficient areas benefit from treat-
ment doses of vitamin A; in South Africa mortality in 
measles patients given vitamin A treatment doses was 2.2% 
compared to 10.3% in placebo controls. Vitamin A has a 
direct and positive effect on the human immune response. 
The protective mechanism is pardy due to maintenance of 
mucosal integrity and pardy through a direct effect on the 
immune response. Children with low vitamin A levels have 
lower measles-specific antibody levels (2) and children with 
vitamin A defici .. ncy (severe enough to cause xerophthalmia) 
have lower CD4/CD8 ratios. lower CD4 native T cells and 
higher proponions of CD8 ceIIs.When children were given 
vitamin A supplements this effect was reversed (3-4). 
The most accepted method to protect the population 
from measles is to immunize the susceptible population. At 
leash 95% of the population must have immunity for the 
population to develop herd immunity. In developing coun-
tries elimination of measles depends on effective herd immu-
nity to protect nonvaccinated inf.mts (under 9 months of 
age). If this is not achieved epidemics can be expected to 
occur every 2-5 years as the number of susceptible unvacci-
nated children in the population increases. In developing 
countries the majority of inf.mts become susceptible shoedy 
afrer the age of 4 months. Immunization is recommended at 
9 months leaving a window of high risk of death from 
measles between 4 and 9 months. 
We sought to investigate the characteristics of measles 
patients admitted to Queen Elizabeth Central Hospital to 
determine: 
(a) the clinical outcome and factors associated with 
poor outcome. 
(b) referral patterns and practices of this population 
and 
(c) the contribution of preexisting vitamin A status to 
morbidity and mortality. In this paper we present 
the findings related to clinical outcome and factors 
associated with poor outcome to assist in the assess-
ment of current strategies of measles eradication in 
Malawi. 
Vitamin A given early in the course of measles 
significandy decreases morbidity and mor-
tality. 
Materials & Methods 
In the 12 month period from March 1992 to February 1993 
we prospectively studied all children who were consecutively 
admitted to Queen Elizabeth Central Hospital with measle 
severe enough to warrant admission. All the children wen 
nursed in a special ward reserved for measles cases. A ques 
tionnaire was developed and pretested prior to start of th 
study. Guardians of all children were interviewed within 
few hours of admission. This was followed by taking a vitc 









































tionnaire covered demographic, immunization and clinical 
information. The children were clinically reviewed on admis-
sion using a standard proforma, in most cases by the same 
paediatrician who assessed them at discharge. All children 
were given treatment doses of vitamin A on admission and, 
where clinically indicated, antibiotics were administered. 
Complications of measles were managed appropriately as 
clinically indicated. Data was entered on microcon:.puter 
and analyzed using SPSS-PC+. 
In the 12 month period there were 266 children admitted; 
most cases occurred in the first two months of the study peri-
od. There were 144 (54.8%) boys and 119 (45.2%) girls. 34 
% of the cases were under 9 months of age and 28.4% were 
over two years of age. 
87% of the patients were from Blantyre District. There 
were 29 deaths (10.9%) and 19 children absconded. 
Mortality was highest (22.5%) in children 12-23 months of 
age. Mortality was only slightly higher in girls (11.8%) than 
in boys (10.4%). We found no association between over-
crowding and outcome (mean number of children <15 .. 3.4 
in both groups) however, we found that mortality was high-
er in singleparent households (14.8%) than in households 
with two or more adults (7.2%) although this difference was 
not statistically different. Children who were not currently 
breast fed had no excess risk of death compared to children 
who were breast fed. 
Vitamin A given early in tbecourse of measles 
significandy decreases morbidity and mor-
tality. 
The commonest complication of measles were predomi-
nantly of the respiratory system. Pneumonia complicated the 
illness of79 children of whom 21 died. Laryngitis and croup 
occurred in 70 children of whom 15 died. Pulmonary TB 
was found in 4 children and one died. Otitis media occurred 
in 127 children (13 died). Ulceration of the mouth occurred 
in 75 children. Most of these were aphthous ulcers and we 
found surprisingly few cases of herpes labialis infection. 
Mortality was associated with pneumonia and laryngitis. 
(Table 1) Pneumonia was more commonly reported in sec-
ondary cases (40%) than in primary cases (28%). Although 
viral conjunctivitis was a presenting symptom in most chIl-
dren, no child had obvious xerophthalmia and no child 
developed severe eye complications. 
, Of 146 children over 9 months of age, 26 children 
(17.8%) had no immunization card or the card that has been 
lost, 76 children (52.1 %) had no record of immunization 
and 44 children (30.1%) had record of being immunized. 
Only 5 children had documented vitamin A supplementa-
tion in the prior six months. 
Discussion 
There is very little remarkable about our data that cannot be 
reproduced in nearly every district hospital in Malawi. We 
present it to review present measles eradication 
strategies. While the contribution of treatment doses of vita-
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min A to reducing mortality is well documented, the contri-
bution of periodic (biannual) vitamin A supplementation on 
the causes of measles remains unclear. 
There were too few children in this study who were sup-
plemented periodically prior to measles onset to assess the 
contribution of periodic vitamin A supplementation in our 
patients. 
Pneumonia is the greatest contributor to 
measles mortality in developing countries. 
None of our patients had evidence of obvious vitamin A 
deficiency as manifested by xerophthalmia. It has been sug-
gested that children who are vitamin A deficient at immu-
nization will not have a sufficient rise in measles antibody to 
offer adequate immunity. Decreased measles antibody 
response has been noted in children with common colds at 
time of vaccination. (5) 
Most children who develop measles under 9 months will 
have protection from waning maternal antibodies. These 
children will also be receiving vitamin A through breast milk 
and are more likely to be vitamin A sufficient. The higher 
mortality in the 12-23 month age group that we observed 
may be due to lack of antibody protection, poor vitamin A 
status, and early introduction of waning foods, as suggested 
in our results. it has been demonstrated that severity of 
measles is associated with prolonged exposure and dose of 
measles virus. (6-8). This is demonstrated by increased sever-
ity in 'the secondary cases. In our population there was no 
increased risk of death in children exposed in the household 
compared to those not exposed in the household however, 
there was an increased risk of severe complications (pneumo-
nia) in secondary cases. It should be noted that amopg chil-
dren who were exposed in the household (n .. 45~ patients 
who died (n .. S) had been exposed to a different sex sibling. 
Of those who survived (n-40) 21 were exposed to a different 
sex sibling. This finding confirms population-based results 
from West Africa (9-10) suggesting that measles cases 
exposed to different sex siblings are more likely to be inten-
sively exposed, as in secondary cases. Similar to the findings 
in these studies patients who died were likely to have 
acquired measles from a sibling older (mean age interval = 
62.4 months) than among patients who survived (mean age 
interval 43.8 months). 
Pneumonia is the greatest contributor to mortality in 
developing countries (11) and in our study population. 
Mortality, at 10.9% in our population, is likely to be an 
under estimate since many deaths occur six to eight weeks 
after onset of symptoms and after discharge from the hospi-
tal. Delayed mortality is higher in children who acquire 
measles before one year of age. (12) These findings suggest 
that secondary exposure in the household does contribute to 
a poor outcome. 
The definitive way of preventing measles is immunization 
of children with the live measles vaccine. In Malawi and most 
developing countries children are vaccinated at 9 months of 
age with the standard Schwartz vaccine. The time of vacci-
nation is an attempt to balance the risk of acquiring infection 
against the risk of poor vaccine uptake because of interfer-
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Table I 
Riak of Death According to Clinical Complication of Meaalea 
Relative Risk 
(95% Confidence 
Clinical Sign %Died %Survived Interval) pvalue 
Otitis media 46.4% 521.3%' 0.89 (0.58, 1.35) NS 
Pneumon4-a 75.0% 26.6% 2.82 (2.07, 3.83) <0.001 
TB 3.6% 1.4% 2.59 (0.28, 24.1) NS 
Post measles 
syndrome 10.7% 7.9% 1.37 (0.43, 4.39) NS 
Laryngitis 53.6% 25.20/0 2.12 (1.40), 3.21) 0.003 
Mouth ulcers 42.9% 28.9% 1.48 (0.92, 2.39) NS 
NS • not significant 
In Malawi where crowded conditions are common in 
urban areaS we can anticipate a proportion of measles cases to 
continue to be under 9 months of age. 
In a highly immunized population a large proportion of 
cases is expected to be among immunized persons. Thus, the 
44 immunized, yet infected children represent expected vac-
cine failures. Measles vaccine failure can range from 1.7-
10% and we cannot attribute the Malawian cases to either 
loss of immunity after initial seroconversion (secondary vac-
cine failure) or inappropriate handling techniques. In our 
immunized patients >8 months of age 20.4% had been 
immunized before 9 months and an additional 22.4% had 
been immunized at 9 months. Secondary vaccine failure is 
not uncommon in patients vaccinated too early. 
The timing of vaccination of 9 months is an 
attempt to balance the risk of acquiring infec-
tion against the risk of poor vaccine uptake 
Our results, although hospital-based and probably not 
representative of the population as a whole, suggests that 
there is much we still need to understand about the epi-
demiolog of measles in Malawi. Patterns of transmission, 
severity, and mortality will continue to change as immuniza-
tion coverage changes, as the population grows and becomes 
more urbanized, and as the impact of the AIDS epidemic 
continues. 
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